Advanced cancer treatment decisions and their patient-facing financial burdens: A thematic analysis
BACKGROUND: Most research about the high costs of cancer care has focused on characterizing and mitigating the financial hardship patients and families experience after cancer-directed therapy. Few studies have examined how these costs prospectively influence treatment decision-making. Even fewer address how costs impact decisions about symptom-directed therapies. We aim to describe how patient-facing costs of care influence decisions about cancer-directed and symptom-directed therapies for advanced cancer. MATERIALS AND METHODS: We analyzed semi-structured interviews with patients, care partners, clinicians, and health system leaders and clinical observations collected by investigators at 3 NCI-designated United States cancer centers between July 2019-May 2021. Two analysts conducted thematic analysis based on the Model of Financial Burden After Cancer Diagnosis. RESULTS: Analysis of 157 interviews and 92 observations identified 4 themes: (1) Insurance influenced treatment choice and location; (2) Medical costs influenced treatment choice, location, and timing; (3) Non-medical costs influenced treatment location and timing; and (4) Employment changes influenced treatment choice and timing. Patients and care partners emphasized costs of symptom-directed therapies; staff focused on costs of cancer-directed therapies. Patients and care partners described how employment influenced decisions about starting or continuing cancer-directed therapy, while staff noted how employment affected decisions about symptom-directed therapy. CONCLUSIONS: Patient-facing costs profoundly influence treatment decisions in advanced cancer care, but differences in perspective among patients, care partners, and clinicians can lead to oversights in treatment decision-making. Eliciting and incorporating patients' varied priorities into treatment decisions can minimize these oversights, better align treatment with goals of care, and reduce financial hardship.
Authors
- Rachel C Forcino (ORCID: https://orcid.org/0000-0001-9938-4830)
- Garrett T. Wasp (ORCID: https://orcid.org/0000-0002-1224-717X)
- Amber E. Barnato (ORCID: https://orcid.org/0000-0003-1080-6270)
- Amanda N. Perry (ORCID: https://orcid.org/0000-0003-1121-4146)
- Diya Mathur
Institutions
- Dartmouth College (US)
- Dartmouth Institute for Health Policy and Clinical Practice (US)
- University of Kansas (US)
- Dartmouth Psychiatric Research Center (US)
Publication Details
- Journal
- The Oncologist
- Published
- 2026-05-27
- DOI
- https://doi.org/10.1093/oncolo/oyag207
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00